Nonmydriatic Fundus Cameras Market The growth in healthcare framework, especially in surfacing nations, is driving the <a target=_blank ...

Demonstrates its commitment to providing quality, cost-saving treatment options to clinicians and the patients they serve.

The company's current commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi® for mydriasis. For more information, ...

Expert Insights and Disease Prevalence Medical professionals and Key Opinion Leaders confirm that Mydriasis affects a significant portion of the population, emphasizing the importance of annual ...

The company’s current commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi® for mydriasis. For more ...